P0560 - Consumer Facing Wearable Technology: Accuracy and Role for Continuous Monitoring During Endoscopic Procedures

Jad AbiMansour, MD, Jyotroop Kaur, MBBS, Saran Velaga, MBBS, Priyanka Vatsavayi, MBBS, Matthew Vogt, MD, Vinay Chandrasekhara, MD
Mayo Clinic, Rochester, MN

Introduction: Consumer facing wearable devices are ubiquitous, capturing an incredible amount of biometric data. The primary aim of this study is to determine whether consumer-facing wearable technology can be harnessed to provide continuous monitoring compared to standard anesthesia monitoring during endoscopic procedures. Secondary aims were to assess patient and provider perceptions of these devices in clinical settings.

Methods: A prospective study of patients undergoing endoscopy with anesthesia support from June 2021 to June 2022 was performed. Prior to endoscopy, patients were provided with a smartwatch (Apple Watch Series 7, Apple Inc, Cupertino, CA) and accessories including continuous ECG monitor and pulse oximeter (Qardio Inc, San Francisco, CA). Data was compared to in-room anesthesia monitor (Aisys CS2, GE HealthCare, Chicago, IL). Both absolute values (e.g., maximum heart rate) and events (e.g., tachycardia) were recorded. Concordance with anesthesia monitoring was assessed with interclass correlation coefficients (ICC). Surveys were then distributed to patients and clinicians, including endoscopists and anesthesia providers, using REDCap electronic data capture tools hosted at our institution. Assessment of convenience, accuracy, and role of smart devices was performed using a 5-point Likert scale and compared between patients and clinicians using Chi-squared testing.

Results: A total of 290 patients undergoing 292 unique procedures were enrolled with a median anesthesia duration of 34 minutes (IQR 25-47) (Table 1). High fidelity readings were successfully recorded with wearable devices for heart rate in 279 (95.5%) cases, oxygen in 203 (69.5%), and respiratory rate in 154 (52.7%). ICCs for watch and accessories are shown in Figure 1A. The wearable devices showed very poor reliability for most clinical parameters with only tachypnea events, minimum SpO2 and tachycardia events demonstrating moderate reliability. Only one patient (0.3%) developed an arrythmia during the procedure, and this was not detected on the wearable devices. Patients generally felt the devices were more accurate and more permissible to wear during a procedure than providers (Figure 1B).

Discussion: Smartwatches, despite dedicated health monitoring accessories, perform poorly for passive data collection compared to gold-standard anesthesia monitoring. Attention should be given to differences in patient and provider perceptions as these devices become more commonly used.




Disclosures:


Jad AbiMansour, MD, Jyotroop Kaur, MBBS, Saran Velaga, MBBS, Priyanka Vatsavayi, MBBS, Matthew Vogt, MD, Vinay Chandrasekhara, MD. P0560 - Consumer Facing Wearable Technology: Accuracy and Role for Continuous Monitoring During Endoscopic Procedures, ACG 2023 Annual Scientific Meeting Abstracts. Vancouver, BC, Canada: American College of Gastroenterology.